Ferroglobe: Third Quarter 2026 Earnings Call - FERROGLOBE PLC

Explicit Guidance:

• Annual EBITDA: Expect an enhancement of approximately $100 million (±15%) once the cost reduction program is fully implemented, driven by increased capacity utilization and streamlining.
• Cost Reduction Implementation: Upfront transformation costs estimated between $40 million and $60 million, net of targeted working capital reductions, to be incurred over an 18-month period.
• Capacity Utilization: Target to boost capacity utilization from current levels (<60%) to 80% through plant consolidation and asset optimization.
• Working Capital: Target a total reduction of $30 million to $40 million as part of the cost restructuring; noted a $32 million release in Q3 2026, with no material changes expected in Q4.
• Dividends: Quarterly dividend of $1.5 million per share (implied $0.015/share based on context, though transcript says "$1.5 per share" likely meaning cents or a typo for $0.015; strictly quoting transcript: "$1.5 per share" scheduled for December 30th).
• Capex: Expect a significant decline in capital expenditures in the fourth quarter following a $20 million spend in Q3.

Business-Segment Outlook:

• Silicon Metal: Volumes down 6% sequentially but up 14% YoY; index prices up 10% in the U.S. and 6% in Europe reflecting trade protection; 2027 contract negotiations anticipated with increased customer interest.
• Silicon-Based Alloys: European volumes declined due to disciplined avoidance of unprofitable prices; excess inventory and import volumes from Malaysia, Bhutan, Azerbaijan, India, and Angola expected to weigh on price recovery; annual review of ferroalloy safeguards expected later in the quarter could drive market improvement in 2027.
• Manganese-Based Alloys: Remains the most consistent segment with strong volumes; outlook remains positive supported by firm pricing and healthy volumes.
• Critical Materials:
  • Pheromone adenine shipments began in Q3 2026; additional shipments expected in Q4 2026.
  • First commercial shipments of other critical ferrometals (ferrovanadium, ferrochromium, low carbon ferromanganese) and trials on "Theraborm" (likely Ferroboron) expected in Q4 2026 for industrial scale validation.
  • 2027 objective is to move from validation to market introduction.
• Operations: Closing five non-strategic plants globally with minimal sales volume impact; restarting Selma (US) for ferroalloys; restarting Venezuela pending OFAC license and electricity reliability; mothballing South African plants in Himalaya and Polokwane due to lack of demand.

Market and Competitive Outlook:

• Trade Protection: Anticipate structural improvements in the European and U.S. markets driven by anti-dumping reviews and safeguards; European Silicon Metal Index rose 7% post-interim review; U.S. index rose 10% post-ITC determination.
• Pricing Dynamics: Expect realized prices to improve as trade measures mitigate predatory import pricing; EU anti-dumping duties on Chinese silicon metal may be applied retroactively.
• Steel Demand: World Steel Association forecasts 2027 finished steel demand growth of 3% in Europe and 2% in North America, supporting ferroalloy business fundamentals.
• Competition: Monitoring import volumes from specific jurisdictions (Malaysia, Bhutan, Azerbaijan, India, Angola) as key price suppressors in the European ferro-silicon market.

Macro / Industry Outlook:

• Economic Indicators: Manufacturing PMI reached 52.9 (52-month high) in the Eurozone and 55.9% in the U.S.; production expected to grow 2% in the U.S. and 3% in Europe.
• Energy Costs: High energy prices remain a primary volatility factor; Q3 EBITDA was negatively impacted by $18.5–19 million in extraordinary energy costs (mainly Spain/Middle East conflict).
• FX and Regulation: Negotiations with the U.S. Department of Energy regarding a domestic supply of critical materials (magnesium, manganese, and seven others) are ongoing; final proposal to be presented in November with negotiations expected to conclude by Q1 2027.
• Geopolitical/Risk: OFAC license for Venezuela operations is pending; electricity supply reliability in Venezuela is a critical prerequisite for restart.

Strategic Initiatives:

• Cost Reduction Program: Aggressive consolidation to 80% capacity utilization, including closing 5 plants and reducing corporate/operational workforce by ~20%; net present value of cash flow and EBITDA improvement expected.
• Critical Materials Platform: Expansion ahead of schedule; leveraging existing furnaces for minimal capital investment in Monzon, Spain; discussions with U.S. government for domestic supply chain.
• Venezuela Restart: Expedited restart preparations initiated; focus on securing OFAC license and resolving electricity supply issues.
• Divestitures/Monitization: Exploring monetization of non-strategic plants via divestitures or conversion to data centers.
• Partnerships/Incentives: Korshell (subsidiary) secured $50 million DOE award for a U.S. gigafactory for graphite-free silicon anode batteries; multiple military customers secured in drone/autonomous vehicle sectors.
• Capacity Additions: Restarting Selma (US) and Venezuela to backfill volumes and increase utilization.

Risks and Headwinds to Outlook:

• Energy Costs: Continued volatility in energy prices (particularly in Spain) could negatively impact margins.
• Market Recovery: Excess inventory and elevated import volumes in Europe could delay ferro-silicon price recovery.
• Regulatory/Geopolitical: Delays in obtaining OFAC license for Venezuela or lack of reliable electricity supply could hinder restart; final determination on EU anti-dumping duties remains pending.
• Execution Risk: The $100 million EBITDA enhancement is contingent on the full implementation of the cost reduction and consolidation plan.
• External Factors: Ongoing Middle East conflict impact on energy costs.

Management Tone on the Future:

• Confidence: Management expresses "decisive action" and "confidence" in the strategic direction despite Q3 results, emphasizing actions within their control (cost structure, capacity utilization).
• Hedges: Acknowledges Q4 will remain challenging due to energy costs and weak European ferro-silicon market; notes specific segments (Silicon Metal) are showing improvement but others (Silicon Alloys) face headwinds.
• Shift: Shifts focus from pure volume growth to profitability and critical materials, positioning the company for long-term benefits "regardless of market conditions."

Miscellaneous:

• Conference Participation: Management will participate in the Stevens Annual Investment Conference in Nashville on November 17th.
• Financial Metrics: Adjusted EBITDA margin was -0.6% in Q3; Cash flow from operations was $26 million; Net debt increased slightly to $42 million; Adjusted gross debt was $135 million.